Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients.

Powell, Jerry S

Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients. [electronic resource] - Blood Mar 2012 - 3031-7 p. digital

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1528-0020

10.1182/blood-2011-09-382846 doi


Adult
Dose-Response Relationship, Drug
Factor VIII--administration & dosage
Half-Life
Hemophilia A--blood
Humans
Immunoglobulin Fc Fragments--administration & dosage
Infusion Pumps
Male
Metabolic Clearance Rate
Middle Aged
Receptors, Fc--administration & dosage
Recombinant Fusion Proteins--administration & dosage
Time Factors
Young Adult
von Willebrand Factor--analysis